MCMedicalCodingSoftware
Free trial
3E0J70M

3E0J70M — Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Antneo Moncln Ab in Bil/Panc Tract, Via Opening

How 3E0J70M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. JBody partThe specific site
  5. 7ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0J70M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0J3NZIntroduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3SFIntroduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3TZIntroduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J4GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach
  • 3E0J704Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J705Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J70MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J728Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J729Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J73ZIntroduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J76ZIntroduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J77ZIntroduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J7BZIntroduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J7GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J7HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
ICD-10-PCSFY2026